Chuang LIU

机构：Brigham and Women's Hospital, Harvard University, China Three Gorges University, National University of Singapore, Yanbian University, China Energy Engineering Corporation (China), AstraZeneca (Brazil), Alexion Pharma (Switzerland), Wuhan Institute of Technology · ORCID：0000-0002-2445-0845

发表论文 357 篇 · 总被引 7060 次 · h-index 45

代表论文

Breaking the PEG barrier to boost mRNA-LNP therapeutics (2025 · Nature Reviews Materials · 被引 10)
Precision uterine mRNA therapy to Restore implantation and fertility (2026 · Materials Today · 被引 6)
Advancing Lung Cancer Treatment: mRNA Therapeutics and Delivery Strategies (2025 · Nano Letters · 被引 6)
Biosensors for the identification of endocrine disrupting chemicals: An emerging technology for toxicity testing (2025 · Coordination Chemistry Reviews · 被引 5)
Programming extracellular protein fate with peptide chimeras (2026 · Chem · 被引 4)
mRNA technology for the prevention and treatment of HIV-1 infection (2026 · Nature Reviews Bioengineering · 被引 4)